These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 30947871

  • 1. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M, Martin P, Carrion AF.
    Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
    [Abstract] [Full Text] [Related]

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 3. Sclerosing Cholangitis in Children and Adolescents.
    Mieli-Vergani G, Vergani D.
    Clin Liver Dis; 2016 Feb 14; 20(1):99-111. PubMed ID: 26593293
    [Abstract] [Full Text] [Related]

  • 4. Hepatobiliary disease in inflammatory bowel disease.
    Ahmad J, Slivka A.
    Gastroenterol Clin North Am; 2002 Mar 14; 31(1):329-45. PubMed ID: 12122741
    [Abstract] [Full Text] [Related]

  • 5. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S.
    Inflamm Bowel Dis; 2023 Sep 01; 29(9):1477-1487. PubMed ID: 36040402
    [Abstract] [Full Text] [Related]

  • 6. The liver in pediatric gastrointestinal disease.
    Vo HD, Xu J, Rabinowitz SS, Fisher SE, Schwarz SM.
    J Pediatr Gastroenterol Nutr; 2014 Sep 01; 59(3):288-99. PubMed ID: 25144777
    [Abstract] [Full Text] [Related]

  • 7. Hepatotoxicity of agents used in the management of inflammatory bowel disease.
    Khokhar OS, Lewis JH.
    Dig Dis; 2010 Sep 01; 28(3):508-18. PubMed ID: 20926880
    [Abstract] [Full Text] [Related]

  • 8. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI, Kang SB.
    Korean J Gastroenterol; 2019 May 25; 73(5):248-259. PubMed ID: 31132831
    [Abstract] [Full Text] [Related]

  • 9. Primary sclerosing cholangitis: a clinical update.
    Williamson KD, Chapman RW.
    Br Med Bull; 2015 Jun 25; 114(1):53-64. PubMed ID: 25981516
    [Abstract] [Full Text] [Related]

  • 10. [Hepatobiliary manifestations in inflammatory bowel disease].
    Solís Herruzo JA, Solís-Muñoz P.
    Rev Esp Enferm Dig; 2007 Sep 25; 99(9):525-42. PubMed ID: 18052648
    [No Abstract] [Full Text] [Related]

  • 11. Update on primary sclerosing cholangitis.
    Karlsen TH, Boberg KM.
    J Hepatol; 2013 Sep 25; 59(3):571-82. PubMed ID: 23603668
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    DeFilippis EM, Kumar S.
    Dig Dis Sci; 2015 Oct 25; 60(10):2873-80. PubMed ID: 25999245
    [Abstract] [Full Text] [Related]

  • 14. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U, Shen B.
    Inflamm Bowel Dis; 2010 Sep 25; 16(9):1598-619. PubMed ID: 20198712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Managing abnormal liver tests in children with inflammatory bowel disease.
    van Rheenen PF.
    Curr Opin Pediatr; 2021 Oct 01; 33(5):521-529. PubMed ID: 34261897
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.